| 000 | 01873 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250513235049.0 | ||
| 264 | 0 | _c20010503 | |
| 008 | 200105s 0 0 eng d | ||
| 022 | _a0270-4137 | ||
| 024 | 7 |
_a10.1002/pros.1041 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWebber, M M | |
| 245 | 0 | 0 |
_aHuman cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. _h[electronic resource] |
| 260 |
_bThe Prostate _cApr 2001 |
||
| 300 |
_a1-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlkylating Agents _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCarcinogenicity Tests |
| 650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
| 650 | 0 | 4 |
_aCell Culture Techniques _xmethods |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aChromosome Disorders |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeratins _xbiosynthesis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylnitrosourea _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNandrolone _xanalogs & derivatives |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xbiosynthesis |
| 650 | 0 | 4 | _aProstatic Neoplasms |
| 650 | 0 | 4 |
_aReceptors, Androgen _xmetabolism |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xpharmacology |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xcytology |
| 700 | 1 | _aQuader, S T | |
| 700 | 1 | _aKleinman, H K | |
| 700 | 1 | _aBello-DeOcampo, D | |
| 700 | 1 | _aStorto, P D | |
| 700 | 1 | _aBice, G | |
| 700 | 1 | _aDeMendonca-Calaca, W | |
| 700 | 1 | _aWilliams, D E | |
| 773 | 0 |
_tThe Prostate _gvol. 47 _gno. 1 _gp. 1-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pros.1041 _zAvailable from publisher's website |
| 999 |
_c11239549 _d11239549 |
||